Skip to main content
. 2024 Nov 15;10(23):e40404. doi: 10.1016/j.heliyon.2024.e40404

Fig. 10.

Fig. 10

2D Structure of compounds (A) N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane] (DB03908); (B) Elobixibat (DB12486); (C) Binding interactions of N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane] (DB03908) at the active site of SARS-CoV-2 3CLpro (PDB ID: 7L13).; (D) Binding interactions of Elobixibat (DB12486) at the active site of SARS-CoV-2 3CLpro (PDB ID: 7L13).